Pharmacokinetics and Drug Metabolism in Animal Studies (ADME, Protein Binding, Mass Balance, Animal Models)
A careful evaluation of the pharmacokinetics and metabolism of a new drug should play an integral and continuing role in the nonclinical workup for that drug, and should be initiated very early in the drug development program. These studies are of primary importance for the planning and design of animal toxicity studies, and for the selection of the appropriate animal model for purposes of estimating a safe clinical dose. Examples of the usefulness of nonclinical pharmacokinetic data for explaining toxicity which occurred, while allowing clinical trials to continue, are presented.
KeywordsParent Drug Toxicity Study Drug Plasma Level Drug Development Program Tissue Distribution Study
Unable to display preview. Download preview PDF.